Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

The label update for Amyvid adds guidance for assessing amyloid plaque levels and may help inform diagnostic and treatment ...

The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in the brain, with new green lights that enable more objective sc | The ...

Scientists at the USC Leonard Davis School of Gerontology have discovered a key connection between high levels of iron in the ...

The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.

Eli Lilly and Company (NYSE:LLY) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy. On June 25, the ...

USC researchers have found a promising new brain scan marker that could better detect Alzheimer’s risk — but only for some.

Scientists in Australia have discovered that a magnetic brain treatment already used for depression can boost the brain’s ...